 | • レポートコード：D0JU09159 • 出版社/出版日：Transparency Market Research / 2020年1月14日 • レポート形態：英文、PDF、204ページ • 納品方法：Eメール • 産業分類：製薬 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、女性健康診断の世界市場について調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、デバイス種類別（生検デバイス、イメージング・モニタリングシステム、キット・試薬、消耗品・付属品）分析、検査種類別（乳がん検査、子宮頸がん検査、出生前遺伝子スクリーニング＆保因者検査、妊娠検査、生殖能力＆排卵検査、感染症検査、その他）分析、エンドユーザー別（病院、診断研究所・画像センター、専門クリニック、その他）分析、地域別分析、競争状況などの構成でお届けいたします。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・女性健康診断の世界市場：デバイス種類別（生検デバイス、イメージング・モニタリングシステム、キット・試薬、消耗品・付属品） ・女性健康診断の世界市場：検査種類別（乳がん検査、子宮頸がん検査、出生前遺伝子スクリーニング＆保因者検査、妊娠検査、生殖能力＆排卵検査、感染症検査、その他） ・女性健康診断の世界市場：エンドユーザー別（病院、診断研究所・画像センター、専門クリニック、その他） ・女性健康診断の世界市場：地域別 ・競争状況 |
Women’s Health Diagnostics Market – Scope of the Report
TMR’s report on the global women’s health diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the mentioned indicators for the market during the forecast period from 2019 to 2027. The report provides the revenue of the women’s health diagnostics market for the period from 2017 to 2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the women’s health diagnostics market for the forecast period from 2019 to 2027.
The report has been prepared after extensive research. Primary research involved bulk of research efforts, wherein analysts conducted interviews with market leaders and opinion makers. Extensive secondary research involved studying key players’ product literature, annual reports, press releases, and relevant documents to understand the women’s health diagnostics market.
Secondary research also includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various phenomenon in the women’s health diagnostics market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments in the scope of the study. Furthermore, the report sheds light on changing competitive dynamics in the women’s health diagnostics market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the women’s health diagnostics market.
The report delves into the competitive landscape of the women’s health diagnostics market. Key players operating in the women’s health diagnostics market have been identified and each one of these has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT analysis are some of the attributes of players in the women’s health diagnostics market profiled in this report.
Key Questions Answered in Women’s Health Diagnostics Market Report
How does the development of women’s health diagnostics provide the scope of growth in the women’s health diagnostics market?
How alliances and partnerships between players are widening the scope of new preservation techniques for women’s health diagnostics?
What are the revenue share projections of key segments under various criteria in the women’s health diagnostics market during the forecast period?
Which segment is likely to generate the highest revenue by the end of the forecast period in 2027?
How is the evolving healthcare system in developing countries in Asia Pacific making an impact on the overall women’s health diagnostics market?
Women’s Health Diagnostics Market – Research Objectives and Research Approach
The comprehensive report on the women’s health diagnostics market begins with an overview section, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives of the study and healthcare compliances laid down by accredited agencies in the purview of line of procedure for women’s health diagnostics.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section further divided into small sections. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.
The report analyzes the women’s health diagnostics market in terms of device type, test type, end user, and region. Key segments under each criteria have been studied at length and the market share for each of these at the end of 2027 has also provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the women’s health diagnostics market.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. 3. Executive Summary: Global Women’s Health Diagnostics Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Women’s Health Diagnostics Market Analysis and Forecast, 2017–2027
4.4.1. Market Revenue Projections (US$ Mn)
5. Global Women’s Health Diagnostics Market Analysis and Forecast, by Device Type
5.1. Introduction
5.2. Key Findings
5.3. Global Women’s Health Diagnostics Market Value Forecast, by Device Type, 2017–2027
5.3.1. Biopsy Devices
5.3.2. Imaging & Monitoring System
5.3.2.1. Ultrasound Devices
5.3.2.2. Mammography Systems
5.3.2.3. MRI Systems
5.3.2.4. Others
5.3.3. Kits & Reagents
5.3.4. Consumables & Accessories
5.4. Global Women’s Health Diagnostics Market Attractiveness, by Device Type
6. Global Women’s Health Diagnostics Market Analysis and Forecast, by Test Type
6.1. Introduction & Definition
6.2. Key Findings
6.3. Global Women’s Health Diagnostics Market Value Forecast, by Test Type, 2017–2027
6.3.1. Breast Cancer Testing
6.3.2. Cervical Cancer Testing
6.3.3. Prenatal Genetic Screening & Carrier Testing
6.3.4. Pregnancy Testing
6.3.5. Fertility & Ovulation Testing
6.3.6. Infectious Disease Testing
6.3.7. Others
6.4. Global Women’s Health Diagnostics Market Attractiveness, by Test Type
7. Global Women’s Health Diagnostics Market Analysis and Forecast, by End-user
7.1. Introduction
7.2. Key Findings
7.3. Global Women’s Health Diagnostics Market Value Forecast, by End-user, 2017–2027
7.3.1. Hospitals
7.3.2. Diagnostic Laboratories & Imaging Centers
7.3.3. Specialty Clinics
7.3.4. Others
7.4. Global Women’s Health Diagnostics Market Attractiveness, by End-user
8. Global Women’s Health Diagnostics Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Global Women’s Health Diagnostics Market Value Forecast, by Region, 2017–2027
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Global Women’s Health Diagnostics Market Attractiveness, by Region
9. North America Women’s Health Diagnostics Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. North America Women’s Health Diagnostics Market Value Forecast, by Device Type, 2017–2027
9.2.1. Biopsy Devices
9.2.2. Imaging & Monitoring System
9.2.2.1. Ultrasound Devices
9.2.2.2. Mammography Systems
9.2.2.3. MRI Systems
9.2.2.4. Others
9.2.3. Kits & Reagents
9.2.4. Consumables & Accessories
9.3. North America Women’s Health Diagnostics Market Value Forecast, by Test Type, 2017–2027
9.3.1. Breast Cancer Testing
9.3.2. Cervical Cancer Testing
9.3.3. Prenatal Genetic Screening & Carrier Testing
9.3.4. Pregnancy Testing
9.3.5. Fertility & Ovulation Testing
9.3.6. Infectious Disease Testing
9.3.7. Others
9.4. North America Women’s Health Diagnostics Market Value Forecast, by End-user, 2017–2027
9.4.1. Hospitals
9.4.2. Diagnostic Laboratories & Imaging Centers
9.4.3. Specialty Clinics
9.4.4. Others
9.5. North America Women’s Health Diagnostics Market Value Forecast, by Country, 2017–2027
9.5.1. U.S.
9.5.2. Canada
9.6. North America Women’s Health Diagnostics Market Attractiveness Analysis
9.6.1. By Device Type
9.6.2. By Test Type
9.6.3. By End-user
9.6.4. By Country
10. Europe Women’s Health Diagnostics Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Europe Women’s Health Diagnostics Market Value Forecast, by Device Type, 2017–2027
10.2.1. Biopsy Devices
10.2.2. Imaging & Monitoring System
10.2.2.1. Ultrasound Devices
10.2.2.2. Mammography Systems
10.2.2.3. MRI Systems
10.2.2.4. Others
10.2.3. Kits & Reagents
10.2.4. Consumables & Accessories
10.3. Europe Women’s Health Diagnostics Market Value Forecast, by Test Type, 2017–2027
10.3.1. Breast Cancer Testing
10.3.2. Cervical Cancer Testing
10.3.3. Prenatal Genetic Screening & Carrier Testing
10.3.4. Pregnancy Testing
10.3.5. Fertility & Ovulation Testing
10.3.6. Infectious Disease Testing
10.3.7. Others
10.4. Europe Women’s Health Diagnostics Market Value Forecast, by End-user, 2017–2027
10.4.1. Hospitals
10.4.2. Diagnostic Laboratories & Imaging Centers
10.4.3. Specialty Clinics
10.4.4. Others
10.5. Europe Women’s Health Diagnostics Market Value Forecast, by Country/Sub-region, 2017–2027
10.5.1. Germany
10.5.2. U.K.
10.5.3. France
10.5.4. Spain
10.5.5. Italy
10.5.6. Rest of Europe
10.6. Europe Women’s Health Diagnostics Market Attractiveness Analysis
10.6.1. By Device Type
10.6.2. By Test Type
10.6.3. By End-user
10.6.4. By Country/Sub-region
11. Asia Pacific Women’s Health Diagnostics Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Asia Pacific Women’s Health Diagnostics Market Value Forecast, by Device Type, 2017–2027
11.2.1. Biopsy Devices
11.2.2. Imaging & Monitoring System
11.2.2.1. Ultrasound Devices
11.2.2.2. Mammography Systems
11.2.2.3. MRI Systems
11.2.2.4. Others
11.2.3. Kits & Reagents
11.2.4. Consumables & Accessories
11.3. Asia Pacific Women’s Health Diagnostics Market Value Forecast, by Test Type, 2017–2027
11.3.1. Breast Cancer Testing
11.3.2. Cervical Cancer Testing
11.3.3. Prenatal Genetic Screening & Carrier Testing
11.3.4. Pregnancy Testing
11.3.5. Fertility & Ovulation Testing
11.3.6. Infectious Disease Testing
11.3.7. Others
11.4. Asia Pacific Women’s Health Diagnostics Market Value Forecast, by End-user, 2017–2027
11.4.1. Hospitals
11.4.2. Diagnostic Laboratories & Imaging Centers
11.4.3. Specialty Clinics
11.4.4. Others
11.5. Asia Pacific Women’s Health Diagnostics Market Value Forecast, by Country/Sub-region, 2017–2027
11.5.1. China
11.5.2. Japan
11.5.3. India
11.5.4. Australia & New Zealand
11.5.5. Rest of Asia Pacific
11.6. Asia Pacific Women’s Health Diagnostics Market Attractiveness Analysis
11.6.1. By Device Type
11.6.2. By Test Type
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Latin America Women’s Health Diagnostics Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Latin America Women’s Health Diagnostics Market Value Forecast, by Device Type, 2017–2027
12.2.1. Biopsy Devices
12.2.2. Imaging & Monitoring System
12.2.2.1. Ultrasound Devices
12.2.2.2. Mammography Systems
12.2.2.3. MRI Systems
12.2.2.4. Others
12.2.3. Kits & Reagents
12.2.4. Consumables & Accessories
12.3. Latin America Women’s Health Diagnostics Market Value Forecast, by Test Type, 2017–2027
12.3.1. Breast Cancer Testing
12.3.2. Cervical Cancer Testing
12.3.3. Prenatal Genetic Screening & Carrier Testing
12.3.4. Pregnancy Testing
12.3.5. Fertility & Ovulation Testing
12.3.6. Infectious Disease Testing
12.3.7. Others
12.4. Latin America Women’s Health Diagnostics Market Value Forecast, by End-user, 2017–2027
12.4.1. Hospitals
12.4.2. Diagnostic Laboratories & Imaging Centers
12.4.3. Specialty Clinics
12.4.4. Others
12.5. Latin America Women’s Health Diagnostics Market Attractiveness Analysis
12.5.1. By Device Type
12.5.2. By Test Type
12.5.3. By End-user
12.5.4. By Country/Sub-region
13. Middle East & Africa Women’s Health Diagnostics Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Middle East & Africa Women’s Health Diagnostics Market Value Forecast, by Device Type, 2017–2027
13.2.1. Biopsy Devices
13.2.2. Imaging & Monitoring System
13.2.2.1. Ultrasound Devices
13.2.2.2. Mammography Systems
13.2.2.3. MRI Systems
13.2.2.4. Others
13.2.3. Kits & Reagents
13.2.4. Consumables & Accessories
13.3. Middle East & Africa Women’s Health Diagnostics Market Value Forecast, by Test Type, 2017–2027
13.3.1. Breast Cancer Testing
13.3.2. Cervical Cancer Testing
13.3.3. Prenatal Genetic Screening & Carrier Testing
13.3.4. Pregnancy Testing
13.3.5. Fertility & Ovulation Testing
13.3.6. Infectious Disease Testing
13.3.7. Others
13.4. Middle East & Africa Women’s Health Diagnostics Market Value Forecast, by End-user, 2017–2027
13.4.1. Hospitals
13.4.2. Diagnostic Laboratories & Imaging Centers
13.4.3. Specialty Clinics
13.4.4. Others
13.5. Middle East & Africa Women’s Health Diagnostics Market Value Forecast, by Country/Sub-region, 2017–2027
13.5.1. GCC Countries
13.5.2. South Africa
13.5.3. Rest of Middle East & Africa
13.6. Middle East & Africa Women’s Health Diagnostics Market Attractiveness Analysis
13.6.1. By Device Type
13.6.2. By Test Type
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Competition Landscape
14.1. Market Players – Competition Matrix (By Tier and Size of companies)
14.2. Market Share Analysis, by Company, 2018
14.3. Company Profiles
14.3.1. Abbott Laboratories
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Financial Overview
14.3.1.3. Product Portfolio
14.3.1.4. SWOT Analysis
14.3.1.5. Strategic Overview
14.3.2. Becton, Dickinson and Company
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Financial Overview
14.3.2.3. Product Portfolio
14.3.2.4. SWOT Analysis
14.3.2.5. Strategic Overview
14.3.3. bioMérieux SA
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Financial Overview
14.3.3.3. Product Portfolio
14.3.3.4. SWOT Analysis
14.3.3.5. Strategic Overview
14.3.4. F. Hoffmann-La Roche AG
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Financial Overview
14.3.4.3. Product Portfolio
14.3.4.4. SWOT Analysis
14.3.4.5. Strategic Overview
14.3.5. GE Healthcare
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Financial Overview
14.3.5.3. Product Portfolio
14.3.5.4. SWOT Analysis
14.3.5.5. Strategic Overview
14.3.6. Hologic, Inc.
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Financial Overview
14.3.6.3. Product Portfolio
14.3.6.4. SWOT Analysis
14.3.6.5. Strategic Overview
14.3.7. Koninklijke Philips N.V.
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Financial Overview
14.3.7.3. Product Portfolio
14.3.7.4. SWOT Analysis
14.3.7.5. Strategic Overview
14.3.8. Quest Diagnostics, Inc.
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Financial Overview
14.3.8.3. Product Portfolio
14.3.8.4. SWOT Analysis
14.3.8.5. Strategic Overview
14.3.9. Cardinal Health
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Financial Overview
14.3.9.3. Product Portfolio
14.3.9.4. SWOT Analysis
14.3.9.5. Strategic Overview
14.3.10. Siemens AG
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Financial Overview
14.3.10.3. Product Portfolio
14.3.10.4. SWOT Analysis
14.3.10.5. Strategic Overview
List of TablesTable 01: Global Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Device Type, 2017–2027
Table 02: Global Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Imaging and Monitoring Systems, 2017–2027
Table 03: Global Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017–2027
Table 04: Global Women's Health Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 05: Global Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 06: North America Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 07: North America Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Device Type, 2017–2027
Table 08: North America Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Imaging and Monitoring System
Table 09: North America Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017–2027
Table 10: North America Women's Health Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 11: Europe Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 12: Europe Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Device Type, 2017–2027
Table 13: Europe Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Imaging and Monitoring System
Table 14: Europe Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017–2027
Table 15: Europe Women's Health Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 16: Asia Pacific Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 17: Asia Pacific Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Device Type, 2017–2027
Table 18: Asia Pacific Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Imaging and Monitoring System
Table 19: Asia Pacific Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017–2027
Table 20: Asia Pacific Women's Health Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 21: Latin America Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 22: Latin America Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Device Type, 2017–2027
Table 23: Latin America Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Imaging and Monitoring System
Table 24: Latin America Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017–2027
Table 25: Latin America Women's Health Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 26: Middle East & Africa Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 27: Middle East & Africa Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Device Type, 2017–2027
Table 28: Middle East & Africa Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Imaging and Monitoring System
Table 29: Middle East & Africa Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017–2027
Table 30: Middle East & Africa Women's Health Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2027